Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$1.84 USD
-0.07 (-3.66%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $1.83 -0.01 (-0.54%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.28 | -36.94% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of -$0.50 per share, beating the Zacks Consensus Estimate of $-0.53 per share. This reflects a positive earnings surprise of 5.66%. Look out for ESPR's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.28 per share, reflecting a year-over-year increase of 64.56%.
Earnings History
Price & Consensus
Zacks News for ESPR
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services